Search Results
Viewing: 31-40 of 142 | All
News
Genetic Testing for Pediatric Epilepsy can be Complicated, but Beneficial
The use of genetic testing in pediatric epilepsy is complicated and the list of known epilepsy genes changes almost daily. The steps from a doctor initially evaluating a patient when they first demonstrate the symptoms of epilepsy to genetic diagnosis remain complex.
News
E. Steve Roach, MD, Honored with 2015 Hower Award from the Child Neurology Society
E. Steve Roach, MD, Chief of Neurology and Vice-Chair of Pediatrics at Nationwide Children's Hospital, has been named the recipient of the 2015 Hower Award by the Child Neurology Society.
News
Nationwide Children's Hospital Chosen as Batten Disease Center of Excellence
Nationwide Children’s Hospital has been selected as a Center of Excellence by the Batten Disease Support and Research Association (BDSRA), the largest research and support organization in North America for families that have children with Batten disease.
Provider
Emily C De Los Reyes
Emily C. De Los Reyes, MD, is an attending pediatric neurologist at Nationwide Children’s and Professor of Clinical Pediatrics and Neurology at The Ohio State University College of Medicine. She serves as director of the Nationwide Children’s Batten Disease Center of Excellence and is lead specialist of the Pediatric Neurology Neurodevelopmental Clinic. She is also the lead autism specialist and the Neurology subspecialty chair of the Autism Treatment Network at Nationwide Children’s. Her research interests include Batten disease, neurodevelopmental disorders and La Crosse encephalitis.
Article
During Your Visit
Find out what to expect during your Pediatric Microsurgery and Facial Reanimation Program visit.
Condition
Atypical Teratoid/Rhabdoid Tumor (ATRT)
An atypical teratoid/rhabdoid tumor (ATRT) is a fast-growing tumor that grows in the brain or spinal cord. ATRTs usually occur in isolation, meaning the tumor does not spread to other parts of the body.
Article
March 2015
Dr. Jerry Mendell discusses phase 1/2a follistatin gene therapy trial for becker muscular dystrophy.
Blog
Duchenne Muscular Dystrophy: Improving Patient Care Through Teamwork
Duchenne Muscular Dystrophy (DMD) is a genetic disease that causes muscle weakness, eventual loss of the ability to walk, and failure of the heart and lung. Boys with DMD typically do not survive past their twenties, but standardization of care and cutting edge research is changing this outlook.
Article
Vagus Nerve Stimulation (VNS)
The Vagus Nerve Stimulator treats epilepsy that is not controlled with medicine. The VNS prevents or lessens the frequency of seizures by sending mild electrical impulses through the vagus nerve to the brain.